Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
40%
Ph phase_2
2
40%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 32 (40.0%)

Trials by Status

active_not_recruiting120%
completed360%
recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_3

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

NCT07104383
active_not_recruitingphase_3

VK2735 for Weight Management Phase 3

NCT07104500
completedphase_2

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

NCT06828055
completedphase_1

Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

NCT05203237
completedphase_2

VK2735 for Weight Management Phase 2

NCT06068946

Clinical Trials (5)

Showing 5 of 5 trials
NCT07104383Phase 3

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Recruiting
NCT07104500Phase 3

VK2735 for Weight Management Phase 3

Active Not Recruiting
NCT06828055Phase 2

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

Completed
NCT05203237Phase 1

Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

Completed
NCT06068946Phase 2

VK2735 for Weight Management Phase 2

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5